it's amazing the linear thinking and methodologies in place
it's amazing the linear thinking and methodologies in place by both NON RETAIL
and those with interest claiming zero investment
exposure via discovery pertains to every *round* undertaken since April 2009
this would include cycles of money in play (that would be both UP and DOWN)
it's not retail that illegally manipulates OTC stox by rote so trolls can trot out the 99% stat
4kids
2
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...
Continue Reading
An Inventor's Eureka Moment Soaks in Innovation Ah, the nifty world of invention never ceases to entertain, does it? This time, a bright mind in Twin City, Georgia, got fed up with the finger-cramping task of scrubbing showers and tubs. Their brainchild? The SPIN & SPRAY, a cleaning tool that sounds like it could be your next best cleaning ally. What Makes SPIN & SPRAY a...
Continue Reading
The Smart Shopper's Guide to Black Friday Tech Black Friday ain't just a race for the cheapest jeans or a half-price TV anymore—now we're talking about smart tech that matters, like Lovense's offerings. Imagine shelling out for something that'll last and deliver genuine satisfaction instead of another closet filler. Yeah, I'm looking at you, cheap gadgets that croak in...
Continue Reading
Reading Between the Financial Lines Nielsen's latest move throws a hefty $1.4 billion worth of senior secured notes into the market, aimed at scooping up DoubleVerify in a play that’s as daring as it is dicey. It's the kind of gamble you discuss with your coffee buddy, sipping something strong enough to wake the dead, and exactly the kind of deal that gets seasoned...
Continue Reading
Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...
Continue Reading
Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...
Continue Reading
Align's Game-Changer in Engine Manufacturing Let's face it, the world of heavy-duty equipment isn't always filled with breakthroughs. But every once in a while, a game-changer rolls off the line, and that's what's happening with Align Production Systems. They've crafted a custom omnidirectional transporter that does more than just move bulky engine assemblies; it...
Continue Reading
Full Sail's Cinematic Spotlight Moment Alright, folks, you're hearing it right: Full Sail University's caught the spotlight in TheWrap Magazine's annual who's-who of film schools for 2026. That's a pat on the back any educational institution would kill for, highlighting that Full Sail is playing with the big boys when it comes to film education. Beyond Classic Classroom...
Continue Reading
A Sudden Pivot Leaves Shareholders Reeling Nothing like a company blindsiding its investors amid the bustling market chaos. Welcome to the iHeartMedia saga, where promises of profit have turned into a bitter pill for shareholders. On November 9, 2026, the radio giant pulled a fast one by drastically revising its full-year Adjusted EBITDA forecast down to $550...
Continue Reading
Launching into Vitiligo Treatment Trials I'll tell you, the biotech world isn't for the faint-hearted, especially when you're juggling hefty terms like 'TYK2/JAK1'. But here we are, watching Accro Bioscience and Fosun Pharma dive headlong into the vitiligo space with this Phase II/III trial of AC-201. They've bagged the IND clearance, and now the first patient is in the...
Continue Reading
Top 5 Most Recently Viewed Articles
Magnet Defense and ATG: A Strategic Acquisition for AI Solutions In a significant move for national security, Magnet Defense LLC announced its definitive agreement to acquire Advanced Technology Group (ATG). This partnership is set to enhance Magnet Defense's capabilities in AI-driven autonomous maritime platforms. With this acquisition, Magnet Defense aims to integrate...
Continue Reading
Avoiding Ecommerce Pitfalls: Essential Insights for Growth Ecommerce businesses face a myriad of challenges in the fast-paced digital marketplace. Understanding and avoiding common mistakes is vital for success. InboxArmy, a leading email marketing agency, has crafted a comprehensive guide titled "8 Common Ecommerce Mistakes to Avoid" to help businesses navigate these...
Continue Reading
Sibanye-Stillwater's Data Breach Investigation Overview Sibanye-Stillwater is currently under significant scrutiny following a data breach that has led to an investigation. This incident involves unauthorized access to their IT systems, which was discovered earlier this year. The mining and metals processing firm, known for its extensive operations, has formally reported...
Continue Reading
Affirm Holdings Announces Upcoming Financial Results Affirm Holdings, Inc. (NASDAQ: AFRM), a leading payment network dedicated to empowering consumers and supporting merchants, is gearing up to unveil its financial performance for the first quarter of fiscal year 2025. This exciting announcement will be made public on November 7, following the end of the trading day. What...
Continue Reading
ASST Stock Hits 52-Week Low Amid Market Volatility Recently, ASST stock has met a challenging phase, plunging to a 52-week low of just $0.6. This notable decline encapsulates a larger trend affecting the asset, which has suffered a significant drop over the past year, noted at a staggering -62.89%. Investors are paying close attention as the stock endeavors to navigate...
Continue Reading